RT: For Decision Makers in Respiratory Care
  • Disorders & Diseases
    • Chronic Pulmonary Disorders
    • Infectious Diseases
    • Critical Care
    • Cardiopulmonary & Thoracic
    • Sleep Medicine
  • Public Health
    • Smoking
    • Healthcare & Policy
    • Pediatrics
  • Products & Treatment
    • Monitoring & Treatment
    • Diagnostics & Testing
    • Pharmaceuticals
    • Industry & Regulatory News
  • Department Management
    • Clinical
    • Education
    • Conferences & CEU
  • Edition Archive

Select Page

Tag: Vertex Pharma

All

Latest
Trikafta triple-combo Therapy Safe for Cystic Fibrosis Patients Ages 6-11

Trikafta triple-combo Therapy Safe for Cystic Fibrosis Patients Ages 6-11

According to a study published in AJRCCM, Vertex Pharma’s Trikafta...

  • Kaftrio One Step Closer to EU Expanded Approval for Cystic Fibrosis Patients

  • Top 10 Medical Innovations for 2021 Include Trikafta, Bubble CPAP

  • Vertex’s Cystic Fibrosis Pill Gets European Medicines Agency’s Backing

  • Cystic Fibrosis: Costs Forcing Parents to Argentina for Orkambi Generic

  • Vertex CF Drug Combo Significantly Improves Lung Function

  • FDA Approves Expanded Kalydeco Use for Cystic Fibrosis

All

Latest
Sorry, No Posts Found

All

Latest
Sorry, No Posts Found
Sorry, No Posts Found

Resources

  • Edition Archive
  • Featured Reports
  • Podcasts
  • White Papers
  • Webinars
  • Videos
  • Conferences

Helpful Links

  • Marketing Solutions
  • Subscribe
  • Contact Us

MEDQOR INFORMATION SERVICES NETWORK

  • 24×7
  • Axis Imaging News
  • Clinical Lab Products
  • Hearing Review
  • Orthodontic Products
  • Physical Therapy Products
  • Plastic Surgery Practice
  • Rehab Management
  • RT: For Decision Makers in Respiratory Care
  • Sleep Review

Follow Us

  • Facebook
  • Twitter
  • LinkedIn
  • YouTube

Designed by Elegant Themes | Powered by WordPress

  • Privacy Policy
  • Terms of Service
  • Copyright